The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Zonagen, Inc.

Zonagen, Inc.
Nasdaq: ZONA
Change
symbol:
     
 PROFILE
Zonagen zeroes in on your private zones. Its lead drug candidate, VASOMAX, is a pill for male erectile dysfunction. The company is also developing Vasofem, a treatment for female sexual dysfunction. Other products in the pipeline include contraceptives, vaccines for prostate cancer, and an enhanced topical treatment for genital herpes. Drug firm Schering-Plough has licensed the marketing rights to VASOMAX, which was approved in Brazil and in Mexico (under the name Z-Max), but FDA approval in the US has been delayed. Because of these delays, Zonagen has cut its R&D and its staff to reduce costs.

 COMPETITION
ICOS Corporation (ICOS)
Pfizer Inc (PFE)
VIVUS, Inc. (VVUS)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 2.40
1-Yr. Sales Growth: 1,100.0%
Employees: 11
Revenue per employee: $218,181.82

 KEY PEOPLE
• Joseph S. Podolski
    CEO
• Louis Ploth
    CFO

 CONTACT INFO
2408 Timberloch Place, Ste. B-4
The Woodlands, TX 77380
US
Phone: 281-367-5892
Fax: 281-363-8796
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001